Atlas Trials

A New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis

Clinical trial NCT03216928 · COMPLETED

Trial details

NCT number
NCT03216928
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2017-01-01
Primary completion
2020-03-12
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.